Boris Bleijlevens

机构：Genmab (Netherlands) · ORCID：0000-0001-9797-2161

发表论文 53 篇 · 总被引 2769 次 · h-index 22

代表论文

• Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation (2017 · Diabetologia · 被引 608)
• 1001 Ways to run AutoDock Vina for virtual screening (2016 · Journal of Computer-Aided Molecular Design · 被引 216)
• Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis (2018 · Journal of the American College of Cardiology · 被引 196)
• Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi (2016 · The Journal of Immunology · 被引 70)
• Comparative Analysis of Antibodies and Heavily Glycosylated Macromolecular Immune Complexes by Size-Exclusion Chromatography Multi-Angle Light Scattering, Native Charge Detection Mass Spectrometry, and Mass Photometry (2021 · Analytical Chemistry · 被引 64)
• Identification of the ER-resident E3 ubiquitin ligase RNF145 as a novel LXR-regulated gene (2017 · PLoS ONE · 被引 33)